naringenin has been researched along with Coronary Restenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, A; Hu, P; Huang, B; Huang, J; Jiang, Q; Li, L; Li, Y; Shi, W; Wu, Q; Xu, S | 1 |
| Chen, J; Hu, X; Jiang, H; Lu, Z; Xu, C; Zhang, J; Zhou, X | 1 |
2 other study(ies) available for naringenin and Coronary Restenosis
| Article | Year |
|---|---|
Naringenin attenuates carotid restenosis in rats after balloon injury through its anti-inflammation and anti-oxidative effects via the RIP1-RIP3-MLKL signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antioxidants; Carotid Arteries; Coronary Restenosis; Flavanones; Gene Expression Regulation; Glutathione; Hyperplasia; Inflammation; Interleukin-1beta; Male; Malondialdehyde; Oxidative Stress; Proliferating Cell Nuclear Antigen; Protein Kinases; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptor-Interacting Protein Serine-Threonine Kinases; Receptors, Cell Surface; Signal Transduction; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2019 |
Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
Topics: Angiotensin II; Animals; Antioxidants; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Citrus; Coronary Restenosis; Dinoprost; Flavanones; Hyperplasia; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Oxidative Stress; Phytotherapy; Plant Extracts; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase; Transcription Factor RelA; Tunica Intima | 2013 |